Figure 1From: Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1) Treatment schedule. TPF, docetaxel+cisplatin+5-fluorouracil; Tox, determination of induction chemotherapy because of toxicity (did not occur).Back to article page